Accenture's Raised Outlook Fails To Ease Fiscal 2026 Softness Worries: Analyst

Accenture reported strong Q3 results, surpassing analyst estimates with $3.49 EPS and $17.7 billion in sales, prompting an upward revision of its FY25 revenue growth outlook to 6-7% and diluted EPS. Despite this positive momentum, driven by a robust pipeline and improved pricing, investor concerns persist regarding potential softness in FY26 growth. This skepticism stems from a 6.5% constant currency decline in new bookings, a sequential headcount reduction, and a strategic decision to reduce acquisitions due to market conditions. Guggenheim maintained a Buy rating but lowered its price target to $335, reflecting continued investor apprehension about future estimate risk despite the current performance.

Analysis

Accenture delivered a strong third-quarter performance, beating analyst consensus with earnings of $3.49 per share and sales of $17.7 billion, representing an 8% year-over-year increase in U.S. dollars. This momentum prompted management to raise its fiscal year 2025 revenue growth outlook to 6-7% and its EPS forecast to a range of $12.77-$12.89. However, this positive current picture is contrasted by significant investor concerns about the fiscal 2026 outlook. Skepticism is driven by several weakening forward-looking indicators, most notably a 6.5% decline in new bookings in constant currency and a 130 basis point sequential drop in headcount. Furthermore, the company has signaled a more prudent approach to M&A, now targeting a lower inorganic growth contribution of approximately 2% in future years because potential targets are not meeting economic hurdles. While Guggenheim maintains a Buy rating, it has lowered its price target from $360 to $335, reflecting the belief that investor fears about future estimate risk, whether cyclical or structural, are unlikely to diminish in the near term despite the ongoing reorganization under its Reinvention Services unit.

Key Decisions for Investors

• Investors should closely monitor new bookings figures in the coming quarters, as the reported 6.5% decline is a critical leading indicator that conflicts with the optimistic FY25 guidance and signals potential future softness.
• It is prudent to adjust long-term growth models to account for a lower contribution from M&A, as management has explicitly guided for a more conservative ~2% inorganic growth rate due to market conditions.
• Despite the current earnings beat, the lowered price target from Guggenheim underscores significant risk for FY26, suggesting investors should remain cautious on valuation until forward-looking metrics like bookings and headcount show signs of recovery.
• Consider the internal reorganization and focus on technology as long-term positives, but weigh them against the near-term headwinds, including a projected 2% revenue impact in Q4 from DOGE-related issues, which could create volatility.